if you can't measure it, you can't manage it

In the knowledge-driven, increasingly competitive global world, the difference between a leader and a follower is to see and know changes faster, and above all, to USE this knowledge earlier than the others. Knowledge, agility and speed in executing do shape the winner.

PHARMAWISER™ Simulator, a next generation price optimization software, is designed to continuously be on top of any change. This radical invention in the field of sequential dynamic scenario planning, where all meaningful business events and marketing drivers can be continuously updated, makes it possible to immediately predict the interdependent impact of any market place change, any change in pricing regulations and pricing algorithms or any strategic move. Maximally tailored for each product, each indication. With specifics for each country, it measures impact on each custom group of countries, pan-European or globally.

PHARMAWISER™ Simulator is a powerful, myth-breaking, versatile and cost-saving scenario planning engine for anyone dealing with Pharmaceutical Economics. Functions in Pricing & Market Access, Strategic Marketing and Business Development can exploit to the fullest all available in-house Business Intelligence and Health Economics expertise.

Vastly innovating in many areas, PHARMAWISER™ Simulator is the transformational cross-functional strategic pricing, marketing planning and forecasting engine by excellence: By integrating the right pieces of data from the massive silo's of information residing within the company, it makes sense of it all.

Ready for national and international use, also accommodating all countries of ‘New Europe’, even regions within countries or the individual USA states.


Made transparant and easy as a game, now also in Pharma, you can ‘play’ your way to success with the new PHARMAWISER™ Simulator, the newest knowledge technology to steer strategy in the right direction.

Read more <

functions that can be empowered by PHARMAWISER™ Simulator

• Global brand manager 

• Brand team members

• Global strategic product or marketing manager

• Health economics manager

• Pricing manager

• Managing Director

• Business Development manager

• Therapeutic area leader

• Portfolio manager

• Functional area executives

• Business Analyst

• International Demand or Production manager

• Forecasting manager

• Business Intelligence manager

• Market Research executives

questions where PHARMAWISER™ Simulator can support your strategy

• When brand challenged by generic: How high is the risk of value/profit destruction? Assessment of global effect, given spill-over on other countries? What are possible scenario's and which is best strategy to cope?

• For a new brand or new indication: At which launch price and country launch sequence will I maximize revenue and profit?

• How will my initial launch price evolve over time considering the subsequent launches in other countries and the interdependent effects of price referencing -both national and international- and parallel import?

• How will my launch price and launch timing impact the performance in other countries and the global result?

• How to determine the right balance between market share and price given market forces of price elasticity, cross-border trade and referencing?

• How to fast assess the volume potential of in-licensing or pipeline products according to their potential label and price scenario’s?

• What is the best price/label scenario?

• How to tailor Pricing and Reimbursement strategy to possible labeling outcomes?

• How to account for varying information availability at different stages of the new product launch and generate a forecast at each stage?

• What will be the global effect of a forced local price decline of my own brand or that of a competitor?

• What will be the impact of market exclusivity loss? How will I best price my brand post-expiry?

• How to harmonize short-range operational budget planning and long-range strategic planning?

• How to integrate market intelligence, brand management & pricing/health economics inputs in the product planning and forecasting process?

• To what extent will international price referencing offset the impact of parallel trade?

• What consequence does one country's price elasticity have on the global pricing & profit picture?

Read more <